Location History:
- Kensington, MD (US) (1996 - 2014)
- Rockville, MD (US) (2017 - 2022)
Company Filing History:
12 out of 3,539 
3 out of 1,217 
3 out of 1,974 
Years Active: 1996-2022
Title: The Innovative Journey of Donald P Bottaro
Introduction: Donald P Bottaro, a distinguished inventor based in Kensington, MD, has made significant contributions to the field of biomedical research with an impressive portfolio of 16 patents. His work primarily focuses on vascular endothelial growth factor (VEGF) antagonists, which hold promise for treating diseases characterized by pathological angiogenesis.
Latest Patents: Among his most notable recent inventions are the variant VEGF polypeptides that have undergone alterations in their C-terminal heparin binding region to reduce their heparin binding affinity. These innovative variants are recognized for their capability to act as receptor antagonists for VEGF receptors, effectively antagonizing angiogenesis. This research could play a crucial role in developing new therapies for various conditions linked to abnormal blood vessel growth.
Career Highlights: Bottaro's career features pivotal roles within esteemed institutions, including his contributions to the Government of the United States of America as represented by the Secretary of the Department of Health and Human Services, as well as the United States of America represented by the Department of Health.
Collaborations: Throughout his career, Bottaro has collaborated with renowned colleagues such as Stuart A Aaronson and Gagani P Athauda, further amplifying the impact of his work and the development of innovative solutions in his field.
Conclusion: Donald P Bottaro's dedication to innovation and his extensive work on VEGF antagonists underscore his importance as an inventor in the biomedical sector. His relentless pursuit of advancements reflects a commitment to improving healthcare outcomes through targeted research and invention.